Detection and identification of NAP-2 as a biomarker in hepatitis B-related hepatocellular carcinoma by proteomic approach
Open Access
- 1 January 2008
- journal article
- Published by Springer Nature in Proteome Science
- Vol. 6 (1) , 10
- https://doi.org/10.1186/1477-5956-6-10
Abstract
A lack of sensitive and specific biomarkers is a major reason for the high rate of Primary hepatocellular carcinoma (HCC)-related mortality. The aim of this study was to investigate potential proteomic biomarkers specific for HCC.Keywords
This publication has 33 references indexed in Scilit:
- Cancer CXC chemokine networks and tumour angiogenesisPublished by Elsevier ,2006
- Proteomic analysis of differentially expressed proteins in hepatocellular carcinoma developed in patients with chronic viral hepatitis CProteomics, 2005
- Local/Regional and Systemic Treatments of Hepatocellular CarcinomaSeminars in Liver Disease, 2005
- Newer markers for hepatocellular carcinomaGastroenterology, 2004
- Test Characteristics of α-Fetoprotein for Detecting Hepatocellular Carcinoma in Patients with Hepatitis CAnnals of Internal Medicine, 2003
- Prognostic prediction and treatment strategy in hepatocellular carcinomaHepatology, 2002
- Use of proteomic patterns in serum to identify ovarian cancerPublished by Elsevier ,2002
- The role of tumor markers in the diagnosis of hepatocellular carcinoma, with special reference to the des-gamma-carboxy prothrombinLiver Transplantation and Surgery, 1995
- Rapid high-sensitivity peptide mapping by liquid chromatography—mass spectrometryJournal of Chromatography A, 1993
- Generation of the neutrophil-activating peptide NAP-2 from platelet basic protein or connective tissue-activating peptide III through monocyte proteases.The Journal of Experimental Medicine, 1990